These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 9653172)

  • 41. Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.
    Verma D; Thompson J; Swaminathan S
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3609-14. PubMed ID: 26976570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system.
    Kanda T; Yajima M; Ahsan N; Tanaka M; Takada K
    J Virol; 2004 Jul; 78(13):7004-15. PubMed ID: 15194777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus persistence in epithelial cells. LSHTM EBV Research Group.
    Nicholson L; Crawford DH
    Lancet; 1994 Mar; 343(8900):789-90. PubMed ID: 7907741
    [No Abstract]   [Full Text] [Related]  

  • 44. A first-generation packaging cell line for Epstein-Barr virus-derived vectors.
    Delecluse HJ; Pich D; Hilsendegen T; Baum C; Hammerschmidt W
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5188-93. PubMed ID: 10220441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strategies involved in developing an effective vaccine for EBV-associated diseases.
    Moss DJ; Schmidt C; Elliott S; Suhrbier A; Burrows S; Khanna R
    Adv Cancer Res; 1996; 69():213-45. PubMed ID: 8791683
    [No Abstract]   [Full Text] [Related]  

  • 46. Study of Epstein-Barr virus (EBV) transmission by EBV genotyping.
    Lung ML; Li SB; Chang RS
    J Infect Dis; 1991 Jul; 164(1):213-4. PubMed ID: 1647423
    [No Abstract]   [Full Text] [Related]  

  • 47. Entry of herpesviruses into cells: more than one way to pull the trigger.
    Heldwein EE
    Structure; 2009 Feb; 17(2):147-9. PubMed ID: 19217384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Herpesvirus genetics has come of age.
    Wagner M; Ruzsics Z; Koszinowski UH
    Trends Microbiol; 2002 Jul; 10(7):318-24. PubMed ID: 12110210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus genetics: talking about the BAC generation.
    Feederle R; Bartlett EJ; Delecluse HJ
    Herpesviridae; 2010 Dec; 1(1):6. PubMed ID: 21429237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells.
    Bu W; Kumar A; Board NL; Kim J; Dowdell K; Zhang S; Lei Y; Hostal A; Krogmann T; Wang Y; Pittaluga S; Marcotrigiano J; Cohen JI
    Immunity; 2024 Mar; 57(3):559-573.e6. PubMed ID: 38479361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation.
    Sagou K; Sato Y; Okuno Y; Watanabe T; Inagaki T; Motooka Y; Toyokuni S; Murata T; Kiyoi H; Kimura H
    PLoS Pathog; 2024 Feb; 20(2):e1011954. PubMed ID: 38300891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fully Human Herpesvirus-Specific Neutralizing IgG Antibodies Generated by EBV Immortalization of Splenocytes-Derived from Immunized Humanized Mice.
    Theobald SJ; Fiestas E; Schneider A; Ostermann B; Danisch S; von Kaisenberg C; Rybniker J; Hammerschmidt W; Zeidler R; Stripecke R
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 and Epstein-Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests.
    Roessler J; Pich D; Krähling V; Becker S; Keppler OT; Zeidler R; Hammerschmidt W
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infection.
    Wahl A; Yao W; Liao B; Chateau M; Richardson C; Ling L; Franks A; Senthil K; Doyon G; Li F; Frost J; Whitehurst CB; Pagano JS; Fletcher CA; Azcarate-Peril MA; Hudgens MG; Rogala AR; Tucker JD; McGowan I; Sartor RB; Garcia JV
    Nat Biotechnol; 2024 Jun; 42(6):905-915. PubMed ID: 37563299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of LC3-Associated Phagocytosis and Antigen Presentation in Macrophages and B Cells.
    Nopper SL; Schmidt KW; Ligeon LA; Münz C
    Methods Mol Biol; 2023; 2692():311-336. PubMed ID: 37365477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release.
    Uddin MK; Watanabe T; Arata M; Sato Y; Kimura H; Murata T
    J Virol; 2023 Jun; 97(6):e0043723. PubMed ID: 37195206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacterial-Artificial-Chromosome-Based Genome Editing Methods and the Applications in Herpesvirus Research.
    Hao M; Tang J; Ge S; Li T; Xia N
    Microorganisms; 2023 Feb; 11(3):. PubMed ID: 36985163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1.
    Lui WY; Bharti A; Wong NM; Jangra S; Botelho MG; Yuen KS; Jin DY
    PLoS Pathog; 2023 Feb; 19(2):e1011186. PubMed ID: 36802409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epstein-Barr Virus Synergizes with BRD7 to Conquer c-Myc-Mediated Viral Latency Maintenance via Chromatin Remodeling.
    Li S; Yang L; Li Y; Yue W; Xin S; Li J; Long S; Zhang W; Cao P; Lu J
    Microbiol Spectr; 2023 Feb; 11(2):e0123722. PubMed ID: 36728436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of Epstein-Barr Virus Minor Capsid Protein BORF1 by TRIM5α.
    Lin LT; Lu YS; Huang HH; Chen H; Hsu SW; Chang LK
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.